What is the dose of Diphenhydramine (Benadryl) for intravenous (IV) administration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended intravenous (IV) dose of Diphenhydramine (Benadryl) for adults is typically 25-50 mg administered slowly over 2-5 minutes, with a maximum single dose of 50 mg, as stated in the study by 1 and 1.

Key Considerations

  • For children, the IV dose is 1-2 mg/kg/dose up to a maximum of 50 mg per dose.
  • Benadryl should be administered slowly when given IV to avoid hypotension and other adverse effects.
  • The medication can be repeated every 4-6 hours as needed, with a maximum daily dose of 400 mg for adults.

Administration and Monitoring

  • When administering IV Benadryl, patients should be monitored for common side effects including sedation, dizziness, and anticholinergic effects like dry mouth and blurred vision.
  • IV Benadryl works more rapidly than oral formulations, making it useful for urgent treatment of allergic reactions, although epinephrine remains the first-line treatment for anaphylaxis.
  • The medication works by blocking histamine H1 receptors, thereby reducing allergic symptoms like itching, swelling, and hives.

Special Considerations

  • Caution should be used in elderly patients and those with certain conditions like glaucoma, prostatic hypertrophy, or cardiovascular disease.
  • It is essential to note that H1 antihistamines like diphenhydramine are considered second-line therapy to epinephrine and should never be administered alone in the treatment of anaphylaxis, as emphasized in the study by 1.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION: ... Pediatric Patients, other than premature infants and neonates: 5 mg/kg/24 hr or 150 mg/m 2/24 hr. Maximum daily dosage is 300 mg. Divide into four doses, administered intravenously at a rate generally not exceeding 25 mg/min, or deep intramuscularly Adults: 10 to 50 mg intravenously at a rate generally not exceeding 25 mg/min, or deep intramuscularly, 100 mg if required; maximum daily dosage is 400 mg.

The dose of Diphenhydramine (Benadryl) for intravenous (IV) administration is:

  • For pediatric patients (other than premature infants and neonates):
    • 5 mg/kg/24 hr or 150 mg/m 2/24 hr,
    • maximum daily dosage is 300 mg,
    • divide into four doses,
    • administered at a rate generally not exceeding 25 mg/min.
  • For adults:
    • 10 to 50 mg,
    • administered at a rate generally not exceeding 25 mg/min,
    • maximum daily dosage is 400 mg 2.

From the Research

Dose of Diphenhydramine for IV Administration

  • The dose of Diphenhydramine (Benadryl) for intravenous (IV) administration is not consistently reported across studies, but specific instances are mentioned:
    • A dose of 1.25 mg/kg was administered to a 3-month-old infant for sedation 3.
    • A dose of 50 mg intravenously was used in a study comparing diphenhydramine with metoclopramide for acute migraine treatment 4.
  • It's essential to note that the appropriate dose may vary based on the specific medical condition being treated, patient age, and other factors.

Administration and Effects

  • Diphenhydramine can be administered orally, intramuscularly, or intravenously, with different onset times for each route 5.
  • The drug has various effects, including sedation, impairment of psychomotor performance, and cognitive function, which should be considered when choosing a treatment option 6, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cardiac Arrest Following the Administration of Intravenous Diphenhydramine for Sedation to an Infant With Congenital Heart Disease.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2021

Research

Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2008

Research

Diphenhydramine-induced acute dystonia.

Pharmacotherapy, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.